SonoThera has secured another $125 million to take its ultrasound-based gene therapy technology into the clinic.

Bay Area biotech SonoThera is bubbling to a clinical boil after raising a

SonoThera has secured another $125 million to take its ultrasound-based gene therapy technology into the clinic.